A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

October 24, 2012

Hep C Hospital Admissions Spike Fivefold; Those for HIV Drop by Half

Rates of hospital admissions for people living with the hepatitis C virus (HCV) increased fivefold during a 15-year period, while those for people with HIV have dropped nearly 50 percent during the same span, according to a study described at the IDWeek 2012 meeting in San Diego and reported by MedPage Today. Meanwhile, hospital admission rates for people coinfected with both HIV and hepatitis C slightly more than doubled. The University of North Carolina at Chapel Hill study, whose findings are still preliminary and not yet peer-reviewed, examined the annual National Hospital Discharge Surveys from 1996 to 2010 and found 6.6 million hospital admissions coded for HCV, HIV or coinfected serostatus. Specifically, 39 percent of admissions were for HIV, 56 percent for hep C and 5 percent for coinfected patients. Because the analysis began at the advent of the antiretroviral era, HIV death rates unsurprisingly dropped, as did the rates for coinfected patients. Hep C death rates may have dropped as well, but according to Christine Oramasionwu, PharmD, PhD, of UNC-CH, this decrease was the “least pronounced.” The study’s findings are limited by the facts that they were based on retroactive observations and that the data lacked any insight into disease severity.

To read the MedPage Today article, click here.
 

Search: hepatitis C, hep C, HCV, hospital admissions, HIV, 1996, coinfection, Univeristy of North Carolina at Chapel Hill, death rates, IDWeek 2012, MedPage Today, National Hospital Discharge Survey, Christine Oramasionwu


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)


[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter


Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.